Clinical Trial Detail

NCT ID NCT03165994
Title APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

esophagus adenocarcinoma

esophageal carcinoma

esophagus squamous cell carcinoma

gastroesophageal junction adenocarcinoma

Therapies

APX005M + Carboplatin + Paclitaxel

Age Groups: adult senior

No variant requirements are available.